Human mitochondrial tRNA quality control in health and disease A channeling mechanism?

被引:25
|
作者
Belostotsky, Ruth [2 ]
Frishberg, Yaacov [2 ,3 ]
Entelis, Nina [1 ]
机构
[1] Univ Strasbourg, Dept Mol & Cellular Genet, CNRS, Strasbourg, France
[2] Shaare Zedek Med Ctr, Div Pediat Nephrol, Jerusalem, Israel
[3] Hadassah Hebrew Univ, Sch Med, Jerusalem, Israel
关键词
tRNA; mitochondria; human diseases; aminoacyl-tRNA-synthetases; elongation factor Tu; tRNA channelling; AMINOACYL-TRANSFER-RNA; STEADY-STATE LEVELS; MUTANT TRANSFER-RNAS; DNA MUTATION; SACCHAROMYCES-CEREVISIAE; LACTIC-ACIDOSIS; MERRF-SYNDROME; IN-VIVO; EF-TU; SYNTHETASE;
D O I
10.4161/rna.9.1.18009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in human mitochondrial tRNA genes are associated with a number of multisystemic disorders. These single nucleotide substitutions in various domains of tRNA molecules may affect different steps of tRNA biogenesis. Often, the prominent decrease of aminoacylation and/or steady-state levels of affected mitochondrial tRNA have been demonstrated in patients' tissues and in cultured cells. Similar effect has been observed for pathogenic mutations in nuclear genes encoding mitochondrial aminoacyl-tRNA-synthetases, while over-expression of mitochondrial aminoacyl-tRNA synthetases or elongation factor EF-Tu rescued mutated tRNAs from degradation. In this review we summarize experimental data concerning the possible regulatory mechanisms governing mitochondrial tRNA steady-state levels, and propose a hypothesis based on the tRNA channelling principle. According to this hypothesis, interaction of mitochondrial tRNA with proteins ensures not only tRNA synthesis, maturation and function, but also protection from degradation. Mutations perturbing this interaction lead to decreased tRNA stability.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 50 条
  • [11] Human mitochondrial tRNAs in health and disease
    C. Florentz
    B. Sohm
    P. Tryoen-Tóth
    J. Pütz
    M. Sissler
    Cellular and Molecular Life Sciences CMLS, 2003, 60 : 1356 - 1375
  • [12] TRNA processing in human mitochondrial disorders
    Masucci, JP
    Schon, EA
    MOLECULAR BIOLOGY REPORTS, 1996, 22 (2-3) : 187 - 193
  • [13] Mitochondrial quality control in health and cardiovascular diseases
    Atici, Asli E.
    Crother, Timothy R.
    Noval Rivas, Magali
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [14] Mitochondrial Iron in Human Health and Disease
    Ward, Diane M.
    Cloonan, Suzanne M.
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 81, 2019, 81 : 453 - 482
  • [15] Human mitochondrial tRNAs in health and disease
    Florentz, C
    Sohm, B
    Tryoen-Tóth, P
    Pütz, J
    Sissler, M
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (07) : 1356 - 1375
  • [16] Point mutations in the mitochondrial tRNA(Lys) gene: Implications for pathogenesis and mechanism
    Masucci, JP
    Schon, EA
    King, MP
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1997, 174 (1-2) : 215 - 219
  • [17] Defective Mitochondrial tRNA Taurine Modification Activates Global Proteostress and Leads to Mitochondrial Disease
    Fakruddin, Md
    Wei, Fan-Yan
    Suzuki, Takeo
    Asano, Kana
    Kaieda, Takashi
    Omori, Akiko
    Izumi, Ryoma
    Fujimura, Atsushi
    Kaitsuka, Taku
    Miyata, Keishi
    Araki, Kimi
    Oike, Yuichi
    Scorrano, Luca
    Suzuki, Tsutomu
    Tomizawa, Kazuhito
    CELL REPORTS, 2018, 22 (02): : 482 - 496
  • [18] CCA Addition to tRNA: Implications for tRNA Quality Control
    Hou, Ya-Ming
    IUBMB LIFE, 2010, 62 (04) : 251 - 260
  • [19] Mitochondrial quality control in acute kidney disease
    Jingyi Sheng
    Xian Li
    Juan Lei
    WeiHua Gan
    Jiayu Song
    Journal of Nephrology, 2023, 36 : 1283 - 1291
  • [20] Pathogenic Implications of Human Mitochondrial Aminoacyl-tRNA Synthetases
    Schwenzer, Hagen
    Zoll, Joffrey
    Florentz, Catherine
    Sissler, Marie
    AMINOACYL-TRNA SYNTHETASES IN BIOLOGY AND MEDICINE, 2014, 344 : 247 - 292